Used in pharmaceutical synthesis as an intermediate for drugs targeting inflammatory and metabolic disorders. Shows potential in the development of selective enzyme inhibitors due to its triazole and hydroxyethyl-phenyl structure, which enhances binding affinity to target proteins. Also employed in research for prodrug design, where the carboxylic acid group allows for esterification to improve bioavailability. Its polar functional groups contribute to favorable solubility and pharmacokinetic properties in preclinical studies.